Quest Days Sales Outstanding from 2010 to 2025

DGX Stock  USD 166.53  0.09  0.05%   
Quest Diagnostics Days Sales Outstanding yearly trend continues to be fairly stable with very little volatility. Days Sales Outstanding is likely to outpace its year average in 2025. During the period from 2010 to 2025, Quest Diagnostics Days Sales Outstanding regression line of annual values had r-squared of  0 and arithmetic mean of  48.57. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
48.21312804
Current Value
54.35
Quarterly Volatility
6.60443312
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Quest Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quest Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 274.7 M, Interest Expense of 237.3 M or Selling General Administrative of 1.5 B, as well as many indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 0.0208 or PTB Ratio of 2.99. Quest financial statements analysis is a perfect complement when working with Quest Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Quest Diagnostics Correlation against competitors.

Latest Quest Diagnostics' Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of Quest Diagnostics Incorporated over the last few years. It is Quest Diagnostics' Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Quest Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Very volatile
   Days Sales Outstanding   
       Timeline  

Quest Days Sales Outstanding Regression Statistics

Arithmetic Mean48.57
Geometric Mean48.20
Coefficient Of Variation13.60
Mean Deviation4.61
Median47.74
Standard Deviation6.60
Sample Variance43.62
Range24.3728
R-Value0.04
Mean Square Error46.67
R-Squared0
Significance0.89
Slope0.05
Total Sum of Squares654.28

Quest Days Sales Outstanding History

2025 54.35
2024 48.21
2023 47.74
2022 44.13
2021 48.65
2020 58.79
2019 50.22

About Quest Diagnostics Financial Statements

Quest Diagnostics investors use historical fundamental indicators, such as Quest Diagnostics' Days Sales Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Quest Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Sales Outstanding 48.21  54.35 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Quest Stock Analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.